Literature DB >> 12429155

Reduced thrombospondin-1 at presentation predicts disease progression in superficial bladder cancer.

Jonathan Charles Goddard1, Christopher Derek Sutton, Janet Louise Jones, Kenneth John O'Byrne, Roger Clive Kockelbergh.   

Abstract

OBJECTIVES: Superficial bladder cancer (SBC) presents a difficult clinical dilemma at diagnosis as only a small subgroup of patients will subsequently develop invasive disease. Study of cancer biology has found that angiogenesis is central to growth and spread. This study examines the relationship between the angiogenic inhibitory factor Thrombospondin-1 (TSP-1) at initial presentation and subsequent progression of SBC.
METHODS: Using immunohistochemistry, 220 cases of SBC were examined for pattern and extent of expression of TSP-1 at initial presentation.
RESULTS: TSP-1 was detected in perivascular tissue, at the epithelial-stromal junction, in the stroma and in tumour cells and reduced perivascular TSP-1 staining at presentation was an independent predictive factor for the subsequent development of muscle invasive or metastatic disease.
CONCLUSION: This adds further weight to the theory that TSP-1 plays a major part in the biology of bladder cancer possibly through the control of angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12429155     DOI: 10.1016/s0302-2838(02)00372-x

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  10 in total

1.  The role of structural extracellular matrix proteins in urothelial bladder cancer (review).

Authors:  Andrea Brunner; Alexandar Tzankov
Journal:  Biomark Insights       Date:  2007-11-05

Review 2.  Roles of main pro- and anti-angiogenic factors in tumor angiogenesis.

Authors:  Zhi Huang; Shi-Deng Bao
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

Review 3.  Thrombospondin-1 in urological cancer: pathological role, clinical significance, and therapeutic prospects.

Authors:  Yasuyoshi Miyata; Hideki Sakai
Journal:  Int J Mol Sci       Date:  2013-06-07       Impact factor: 5.923

4.  Thrombospondin-1 expression in urothelial carcinoma: prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix components.

Authors:  E Ioachim; M C Michael; M Salmas; K Damala; E Tsanou; M M Michael; V Malamou-Mitsi; N E Stavropoulos
Journal:  BMC Cancer       Date:  2006-05-29       Impact factor: 4.430

Review 5.  Tissue-based molecular markers in upper tract urothelial carcinoma and their prognostic implications.

Authors:  Ricardo L Favaretto; Stênio C Zequi; Renato A R Oliveira; Thiago Santana; Walter H Costa; Isabela W Cunha; Gustavo C Guimarães
Journal:  Int Braz J Urol       Date:  2018 Jan-Feb       Impact factor: 1.541

6.  Thrombospondin-1-derived 4N1K peptide expression is negatively associated with malignant aggressiveness and prognosis in urothelial carcinoma of the upper urinary tract.

Authors:  Yasuyoshi Miyata; Shin-ichi Watanabe; Hiroshi Kanetake; Hideki Sakai
Journal:  BMC Cancer       Date:  2012-08-28       Impact factor: 4.430

7.  Elevated osteopontin and thrombospondin expression identifies malignant human breast carcinoma but is not indicative of metastatic status.

Authors:  Jessica Wang-Rodriguez; Virginia Urquidi; Amber Rivard; Steve Goodison
Journal:  Breast Cancer Res       Date:  2003-07-09       Impact factor: 6.466

8.  Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: a role for thrombospondin-1.

Authors:  Aimee M Johnson; Mary J O'Connell; Hiroshi Miyamoto; Jiaoti Huang; Jorge L Yao; Edward M Messing; Jay E Reeder
Journal:  BMC Urol       Date:  2008-04-23       Impact factor: 2.264

9.  TSP-1-1223 A/G Polymorphism as a Potential Predictor of the Recurrence Risk of Bladder Cancer in a Chinese Population.

Authors:  Xiao Yang; Pengchao Li; Xuejian Yang; Chao Qin; Qiang Cao; Zhengdong Zhang; Meilin Wang; Hongzhou Cai; Jinbao Gu; Jun Tao; Min Gu; Qiang Lu; Changjun Yin
Journal:  Int J Genomics       Date:  2013-12-03       Impact factor: 2.326

10.  Novel circulating peptide biomarkers for esophageal squamous cell carcinoma revealed by a magnetic bead-based MALDI-TOFMS assay.

Authors:  Kun Jia; Wei Li; Feng Wang; Haixia Qu; Yuanyuan Qiao; Lanping Zhou; Yulin Sun; Qingwei Ma; Xiaohang Zhao
Journal:  Oncotarget       Date:  2016-04-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.